ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,221.94
-0.31%
Dow Jones
38,963.78
-0.38%
Gold vs US Dollar
2,298.05
-0.98%
Brent Oil
84.58
0.47%
Bitcoin
61,796.42
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) News

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IOVA
DateTimeSourceHeadlineSymbolCompany
21/06/202422:00GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
13/06/202423:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
13/06/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
11/06/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
06/06/202401:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
06/06/202401:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
06/06/202401:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
03/06/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
24/05/202421:01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming Conferences and EventsNASDAQ:IOVAIovance Biotherapeutics Inc
23/05/202422:00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
17/05/202422:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IOVAIovance Biotherapeutics Inc
17/05/202422:15GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202421:01GlobeNewswire Inc.Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
01/05/202411:01GlobeNewswire Inc.Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
30/04/202411:01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming ConferencesNASDAQ:IOVAIovance Biotherapeutics Inc
24/04/202421:01GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
19/04/202422:15GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
22/03/202421:30GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
06/03/202423:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
05/03/202422:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
05/03/202422:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
05/03/202422:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
05/03/202422:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
05/03/202422:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
05/03/202422:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
04/03/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
04/03/202411:30GlobeNewswire Inc.Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IOVA

Your Recent History

LSE
77CM
Nationwde. 29
TSXV
AMC
Arizona Metals
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved